期刊文献+

miR-124通过靶向调控DNMT3B抑制胃癌细胞增殖 被引量:4

MiR-124 Suppresses Cell Proliferation by Targeting DNMT3B in Gastric Carcinoma
下载PDF
导出
摘要 目的明确miR-124是否通过靶向调控DNA甲基化转移酶3B(DNA methyltransferase 3B,DNMT3B)表达而抑制胃癌细胞增殖能力,从而揭示miR-124的抑瘤分子机制。方法采用MTT检测miR-124对人胃癌MKN-45细胞的增殖能力;构建DNMT3B 3'UTR-荧光素酶报告载体,通过荧光素酶报告检测观察miR-124对DNMT3B3'UTR-荧光素酶活性的影响;将miR-124 mimics转染胃癌细胞MKN-45,采用Western blot检测DNMT3B表达水平。结果 MTT结果显示,在转染miR-124 mimics 24、48和72 h后OD值(0.264±0.023、0.377±0.041、0.524±0.029)分别与对照组(0.414±0.051、0.619±0.065、0.898±0.072)比较,差异均有显著性(均P<0.05),且具有时间依赖性;荧光素报告载体系统证实DNMT3B是miR-124直接调控的靶基因。Western blot结果显示,miR-124可抑制DNMT3B蛋白的表达。结论 miR-124通过靶向调控DNMT3B的表达而抑制胃癌细胞增殖能力。 Objective To explicit whether miR-124 suppresses cell proliferation by targeting DNMT3B, thus to re- veal molecular mechanism of miR-124 function as a tumorsuppressor in gastric carcinoma. Methods DNMT3B 3'UTR- lueiferase vector was constructed and luciferase reporter gene assay was employed to examine the effect of miR-124 on lucif- erase activity. MKN-45 cells were transfeeted with miR-124 mimics, and next Western blotting was performed to detect the expressions of DNMT3B protein. Results After transfection of miR-124 mimics for 24 h, 48 h ,72 h respectively, MTT assay showed that the OD values were (0.264 ±0. 023), (0. 377 ±0.041 ) and (0. 524 ±0. 029) ,compared with the con- trol group (0. 414 ±0. 051), (0. 619 ±0. 065) and (0. 898 ±0. 072) ,the groups were significantly different ( all P 〈 0. 05 ) ,and it is on a time-dependent manner. Luciferase reporter vector system confirmed that DNMT3B was a target gene of miR-124. Western blot showed that the expressions of DNMT3B protein were inhibited by miR-124. Conclusion miR- 124 suppresses cell proliferation by targeting DNMT3B in gastric carcinoma.
出处 《中南医学科学杂志》 CAS 2013年第1期10-12,共3页 Medical Science Journal of Central South China
基金 国家自然科学基金(31100935)
关键词 胃癌 miR-124 DNMT3B 细胞增殖 gastric carcinoma miR-124 DNMT3B cell proliferation
  • 相关文献

参考文献12

  • 1Ghanta KS, Li DQ, EswaranJ, et al. Gene profiling of MTAI identifies novel gene targets and functions[J]. PLoS One,20ll ,6(2) :eI7135.
  • 2Wilting SM, van Boerdonk RA, Henken FE, et al. Methylation?mediated silencing and tumour suppressive function of hsa?miR-124 in cervical cancer[J]. Mol Cancer ,2010 ,9(1) : 167.
  • 3Furuta M, Kozaki KI, Tanaka S, et al. miR -124 and miR- 203 are epigenetically silenced tumor-suppressive mi?croRNAs in hepatocellular carcinoma[J]. Carcinogene?sis,2010,31(5) :766-776.
  • 4Li KK, PangJC, Ching AK, et al. miR-124 is frequently down-regulated in medulloblasto and is a negative regula?tor of SLCI6AI[J]. Hum Pathol,2009,40(9) :1234-1243.
  • 5PiersonJ, Hostager B, Fan R, et al. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblas?toma[J].J Neurooncol ,2008 ,90( I ) : 1-7.
  • 6Hunt S,Jones AV,Hinsley EE,etal. MicroRNA-124 sup?presses oral squamous cell carcinoma motility by targeting ITGBI[J]. FEBS Lett ,2011,585 (1) : 187 -192.
  • 7SilberJ, Lim DA, Petritsch C, et al. miR-124 and miR- 137 inhibit proliferation of glioblastoma multi forme cells and induce differentiation of brain tumor stem cells[J] . BMC Med ,2008,6: 14.
  • 8吕辉,唐云云,唐海林,张志伟,周秀田,罗招阳.miR-124在胃癌中的表达及其临床意义[J].医学临床研究,2012,29(3):388-390. 被引量:11
  • 9唐海林,苏坚,邓敏,曾希,廖前进,周秀田,苏琦.胃癌组织中miR-222与TIMP3的表达及临床意义[J].中国肿瘤临床,2012,29(4):194-196. 被引量:12
  • 10唐海林,邓敏,廖前进,曾希,周秀田,苏琦.结肠癌组织中miR-185的表达及其临床意义[J].中南医学科学杂志,2011,39(5):491-492. 被引量:9

二级参考文献34

  • 1Tomoe Lu,Hiroshi Hano,Keisuke Nagatsuma,Satoru Chiba,Masahiro Ikegami.Frequent loss of heterozygosity in two distinct regions,8p23.1 and 8p22, in hepatocellular carcinoma[J].World Journal of Gastroenterology,2007,13(7):1090-1097. 被引量:12
  • 2Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature, 2005, 435 (7043) :834-838.
  • 3Rigoutsos I, Furnari F. Gene-expression forum: decoy for microRNAs. Nature, 2010, 465 (7301) : 1016-1017.
  • 4Rao SA, Santosh V, Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod Pathol, 2010, 23 (10) :1404-1417.
  • 5Scapoli L, Palmieri A, Lo Muzio L, et al. MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression. Int J Immunopathol Pharmacol, 2010, 23 ( 4 ): 1229- 1234.
  • 6Slattery ML, Wolff E, Hoffman MD, et al. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer, 2011,50(3) :196-206.
  • 7Liu K, Wang G, Ding H, et al. Downregulation of metastasis suppressor 1 ( MTSS1 ) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMC Cancer, 2010, 10:428.
  • 8Yamashita S, Tsujino Y, Moriguchi K, et al. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci, 2006, 97 ( 1 ) :64-71.
  • 9Utikal J, Gratchev A, Muller-Molinet I, et al. The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer, 2006,119 (10) :2287-2293.
  • 10Zhu LH, Liu T, Tang H, et al. MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J, 2010, 277 (18) : 3726-3734.

共引文献44

同被引文献36

  • 1王临虹,邱琇,郑睿敏,狄江丽.我国宫颈癌流行病学状况及防治策略的回顾与展望[J].中国妇幼卫生杂志,2010,1(3):146-149. 被引量:76
  • 2吕丽红,张波,曾庆东,邵军,尹金岺.5-LOXmRNA和VEGFmRNA在胰腺癌中的表达及其临床意义[J].中国普通外科杂志,2005,14(11):813-816. 被引量:3
  • 3Bourne TD, Schiff D. Update on molecular findings, management and outcome in low-grade gliomas[J]. Nat Rev Neurol, 2010(6):695-701.
  • 4Zhang B, Pan X, Cobb GP, et al. microRNAs as oncogenes and tumor suppressors[J]. Dev Biol, 2007,302:11 - 12.
  • 5Wilting SM, van Boerdonk RA, Henken FE, et al. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical eaneer[J]. Mol Cancer.2010(9):167.
  • 6Li KK, Pang JC, Ching AK, et al. miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1 [J].Hum Pathol, 2009,40(9): 1234-1243.
  • 7Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues[J]. BMC Genomics,2007, 8:166.
  • 8Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive of human renal allograft status[J]. Proc Natl Acad Sci U S A, 2009, 106(13): 5330-5335.
  • 9Chen CZ. MicroRNAs as oncogenes and tumor suppressors[J]. N Engl J Med, 2005, 353(17): 1768-1771.
  • 10Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies[J]. Cancer Prev Res (Phila), 2012, 5(3):492-497.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部